[Lamivudine treatment: realities and expectations].
Crespo
J
J
Pons-Romero
F
F
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use; D004279:DNA, Viral / Q000032:analysis / Q000187:drug effects; D006678:HIV / Q000187:drug effects / Q000276:immunology; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D006515:Hepatitis B virus / Q000187:drug effects / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000150:complications / Q000188:drug therapy / Q000628:therapy; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D019259:Lamivudine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D016133:Polymerase Chain Reaction
D019380:Anti-HIV Agents; D000998:Antiviral Agents; D004279:DNA, Viral; D019259:Lamivudine; D007372:Interferons